BTK inhibitors potently impair platelet aggregation as a class effect independent of BTK specificity or dose in CLL and MCL

Journal of Clinical and Experimental Hematopathology · Published 2025-01-01 · DOI 10.3960/jslrt.25028

Authors being retrieved — see the publisher record. https://doi.org/10.3960/jslrt.25028

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2025

Related articles